[논문]The water extract of Sophorae tonkinensis Radix et Rhizoma alleviates non-alcoholic fatty liver disease and its mechanism

Zhao, Qing; Wei, Mengjuan; Zhang, Shaobo; Huang, Zhenlin; Lu, Bin; Ji, Lili

doi:10.1016/j.phymed.2020.153270

[해외논문] The water extract of Sophorae tonkinensis Radix et Rhizoma alleviates non-alcoholic fatty liver disease and its mechanism

Phytomedicine : international journal of phytotherapy and phytopharmacology, v.77, 2020년, pp.153270 -

Zhao, Qing (Corresponding author.) , Wei, Mengjuan , Zhang, Shaobo , Huang, Zhenlin , Lu, Bin , Ji, Lili

Abstract ▼ AI-Helper

Abstract Background Sophorae tonkinensis Radix et Rhizoma is traditionally used for clearing away heat and toxic materials in China. Purpose This study aims to observe the amelioration of Sophorae tonkinensis water extract (STR) against non-alcoholic fatty liver disease (NAFLD) and the engaged mechanism. Methods NAFLD was induced in mice fed by methionine and choline deficient (MCD) diet. Liver histological observation, Oil Red O, Masson's trichrome and F4/80 immunohistochemical staining were performed. Serum and liver biochemical parameters, hepatic gene and protein expression were detected. Cellular lipids accumulation in human normal liver l-02 and hepatoma HepRG cells were induced by 0.5 mM nonestesterified fatty acid (NEFA). The contents of matrine (MT) and oxymatrine (OMT) in STR were detected by using high-performance liquid chromatography (HPLC). Carnitine palmitoyltransferase 1A (CPT1A) expression and enzymatic activity were detected both in vivo and in vitro. Results Serum alanine/aspartate aminotransferase (ALT/AST) activity, hepatic malondialdehyde (MDA) content and liver histological observation showed that STR alleviated hepatocellular damage in mice fed with MCD diet. Hepatic triglyceride (TG), total cholesterol (TC) and NEFA amounts, and Oil Red O staining showed that STR reduced hepatic lipids accumulation in mice fed with MCD diet. STR and its main compounds including MT and OMT decreased NEFA-induced cellular lipids accumulation in hepatocytes. STR enhanced CPT1A activity both in vivo and in vitro. MT and OMT also enhanced cellular CPT1A activity in l-02 hepatocytes treated with NEFA. Moreover, the CTP1A inhibitor etomoxir (ETO) reduced the lipid-lowering activity provided by STR, MT or OMT in vitro. Liver myeloperoxidase (MPO) activity and hydroxyproline content, Masson's trichrome and F4/80 immunohistochemical staining, and hepatic mRNA expression of some molecules involved in regulating inflammation or fibrosis demonstrated that STR alleviated hepatic inflammation and liver fibrosis in mice fed with MCD diet. Conclusion STR alleviated NAFLD by inhibiting hepatic inflammation and liver fibrosis, and reducing hepatic lipids accumulation through promoting fatty acids β-oxidation by enhancing liver CPT1A activity. MT and OMT may be the main active compounds contributing to the lipid-lowering activity provided by STR. Graphical abstract [DISPLAY OMISSION]

주제어

참고문헌 (36)

Liver Int. Suppl. Araujo 1 47 2018 10.1111/liv.13643 Global epidemiology of non-alcoholic fatty liver disease/non-alcoholic steatohepatitis: what we need in the future

상세보기
Dig. Dis. Sci. Arrese 61 1294 2016 10.1007/s10620-016-4049-x Innate immunity and inflammation in NAFLD/NASH

상세보기
Hepatology Bedossa 60 565 2014 10.1002/hep.27173 Utility and appropriateness of the fatty liver inhibition of progression (FLIP) algorithm and steatosis, activity, and fibrosis (SAF) score in the evaluation of biopsies of nonalcoholic fatty liver disease

상세보기
Hum. Pathol. Brunt 35 1070 2004 10.1016/j.humpath.2004.04.017 Nonalcoholic steatohepatitis : histologic features and clinical correlations with 30 blinded biopsy specimens

상세보기
Metabolism Buzzetti 65 1038 2016 10.1016/j.metabol.2015.12.012 The multiple-hit pathogenesis of non-alcoholic fatty liver disease (NAFLD)

상세보기
J. Hepatol. Byrne 62 1 Suppl S47 2015 10.1016/j.jhep.2014.12.012 NAFLD : a multisystem disease

상세보기
Nutrients Chen 9 E96 2017 10.3390/nu9020096 Effects of natural products on fructose-induced nonalcoholic fatty liver disease (NAFLD)

상세보기
Zhongguo Zhong Yao Za Zhi Chen 42 2439 2017 Pharmacological effect and toxicology of Sophorae Tonkinensis Radix et Rhizoma

상세보기
27 2015 Pharmacopeia of Thepeople's Republic of China (2015) Version
J. Clin. Exp. Hepatol. Choudhary 9 731 2019 10.1016/j.jceh.2019.06.004 Peroxisome proliferator-activated receptors and their agonists in nonalcoholic fatty liver disease

상세보기
Gastroenterology Dela Pena 129 1663 2005 10.1053/j.gastro.2005.09.004 NF-kappaB activation, rather than TNF, mediates hepatic inflammation in a murine dietary model of steatohepatitis

상세보기
Diabetes Dibba 6 83 2018 Emerging therapeutic targets and experimental drugs for the treatement of NAFLD
Hepat. Med. Ganguli 11 159 2019 10.2147/HMER.S188991 A review of current and upcoming treatment modalities in non-alcoholic fatty liver disease and non-alcoholic steatohepatitis
J. Transl. Med. Gao 16 319 2018 10.1186/s12967-018-1685-2 Matrine attenuates endoplasmic reticulum stress and mitochondrion dysfunction in nonalcoholic fatty liver disease by regulating SERCA pathway

상세보기
Cell Death. Dis. George 10 18 2019 10.1038/s41419-018-1272-8 Molecular mechanisms in the pathogenesis of N-nitrosodimethylamine induced hepatic fibrosis

상세보기
Hepatol. Int. Golabi 13 688 2019 10.1007/s12072-019-09995-8 Hepatocellular carcinoma and non-alcoholic fatty liver disease

상세보기
Annu. Rev. Physiol. Houten 78 23 2016 10.1146/annurev-physiol-021115-105045 The biochemistry and physiology of mitochondrial fatty acid β-oxidation and its genetic disorders

상세보기
Dig. Dis. Sci. Ibrahim 61 1325 2016 10.1007/s10620-015-3977-1 Animal models of nonalcoholic steatohepatitis : eat, delete, and inflame

상세보기
Int. J. Clin. Exp. Pathol. Itagaki 6 2683 2013 Morphological and functional characterization of non-alcoholic fatty liver disease induced by a methionine-choline-deficient diet in C57BL/6 mice
Hepatology Kleiner 41 1313 2005 10.1002/hep.20701 Design and validation of a histological scoring system for nonalcoholic fatty liver disease

상세보기
Arch. Pharm. Res. Lee 42 935 2019 10.1007/s12272-019-01178-1 Molecular insights into the role of mitochodnria in non-alcoholic fatty liver disease

상세보기
World J. Gastroenterol. Liu 23 1964 2017 10.3748/wjg.v23.i11.1964 Traditional Chinese herbal extracts inducing autophagy as a novel approach in therapy of nonalcoholic fatty liver disease

상세보기
Curr. Pharm. Des. Lonardo 19 5177 2013 10.2174/1381612811319290003 Cardiovascular and systemic risk in nonalcoholic fatty liver disease-atherosclerosis as a major player in the natural course of NAFLD

상세보기
Cell Mol. Life Sci. Mandard 61 393 2004 10.1007/s00018-003-3216-3 Peroxisome proliferator-activated receptor alpha target genes

상세보기
J. Hepatol. Mridha 66 1037 2017 10.1016/j.jhep.2017.01.022 NLRP3 inflammasome blockage reduces liver inflammation and fibrosis in experimental NASH in mice

상세보기
J. Hepatol. Pawlak 62 720 2015 10.1016/j.jhep.2014.10.039 Molecular mechanism of PPARα action and its impact on lipid metabolism, inflammation and fibrosis in non-alcoholic fatty liver disease

상세보기
PLoS ONE Rakhshandehroo 4 e6796 2009 10.1371/journal.pone.0006796 Comparative analysis of gene regulation by the transcription factor PPARalpha between mouse and human

상세보기
Lab. Anim. Ramadori 49 1 Suppl 47 2015 10.1177/0023677215570078 Mouse models of metabolic liver injury

상세보기
Hepatol. Int. Reimer 14 8 2020 10.1007/s12072-019-10001-4 New drugs for NAFLD : lessons from basic models to the clinic

상세보기
J. Lipid Res. Rinella 49 1068 2008 10.1194/jlr.M800042-JLR200 Mechanisms of hepatic steatosis in mice fed a lipogenic methionine choline-deficient diet

상세보기
Cell Metab. Samuel 27 22 2018 10.1016/j.cmet.2017.08.002 Nonalcoholic fatty liver disease are a nexus of metabolic and hepatic diseases

상세보기
Eur. J. Pharmacol. Shi 714 89 2013 10.1016/j.ejphar.2013.06.013

상세보기
J. Clin. Exp. Hepatol. Thiagarajan 9 515 2019 10.1016/j.jceh.2019.03.002 Drug development for nonalcoholic fatty liver disease : landscape and challenges

상세보기
Ann. Neurosci. Vishwanath 23 51 2016 10.1159/000443556 Fatty Acid Beta-Oxidation Disorders: a Brief Review

상세보기
Curr. Drug Targets Xu 16 1347 2015 10.2174/1389450116666150531155711 Natural products on nonalcoholic fatty liver disease

상세보기
Front. Pharmacol. Zhang 9 1459 2018 10.3389/fphar.2018.01459 Herbal extracts and natural products in alleviating non-alcoholic fatty liver disease via activating autophagy

상세보기

내보내기 구분	파일저장 인쇄 메일전송
구성항목	기본정보 상세정보 관리번호, 논문명, 저널/프로시딩명, 저자 , 발행년, 권, 호, 시작페이지, 끝페이지, 발행기관 관리번호, 논문명, 대등논문명, 저자 , 저널/프로시딩명, 발행기관, 발행년, 발행언어, 권, 호, 시작페이지, 끝페이지, ISBN, ISSN, 주제분야, 키워드, 초록(한글), 초록(영문), 저자(소속기관)
저장형식	Text(ASCII format) Excel format RefWorks Direct Export RIS format (for Reference Manager, ProCite, EndNote), Scholar's Aids, Mendeley
메일정보	받는사람 (필수) @ 보내는사람 (선택) @ 제목 내용 KISTI 검색결과 이메일 서비스
안내	총 건의 자료가 검색되었습니다. 다운받으실 자료의 인덱스를 입력하세요. (1-10,000) 검색결과의 순서대로 최대 10,000건 까지 다운로드가 가능합니다. 데이타가 많을 경우 속도가 느려질 수 있습니다.(최대 2~3분 소요) 다운로드 파일은 UTF-8 형태로 저장됩니다. 파일의 내용이 제대로 보이지 않을실 때는 웹브라우저 상단의 보기 -> 인코딩 -> 자동선택 여부를 확인하십시오. ~ Text(ASCII format) Excel format

연합인증

[해외논문] The water extract of Sophorae tonkinensis Radix et Rhizoma alleviates non-alcoholic fatty liver disease and its mechanism

Abstract ▼ AI-Helper

주제어

참고문헌 (36)

이 논문을 인용한 문헌

관련 콘텐츠

원문 URL 링크

연관된 기능

이 논문과 함께 이용한 콘텐츠

AI-Helper ※ AI-Helper는 오픈소스 모델을 사용합니다.

선택된 텍스트